Wang Xiaolin (CIK 1849181) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-19). Recent activity: Sell RVMD (2,010 shares), Buy RVMD (15,100 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-19 | Revolution Medicines, Inc. (RVMD) | EVP, Clinical Development | Sell | 2,010 | $199,955 |
| 2026-03-03 | Revolution Medicines, Inc. (RVMD) | EVP, Clinical Development | Buy | 15,100 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-03-19